Demester Julien, Brunschweiler Benoit, Mertl Patrice
Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France.
Eur J Orthop Surg Traumatol. 2025 Jul 22;35(1):315. doi: 10.1007/s00590-025-04430-1.
During revision total hip arthroplasty (THA), severe acetabular bone defects are usually treated with bone allograft combined with a metal cage or ring. The purpose of this study was to assess clinical and radiological outcomes after acetabular reconstruction with supercritical CO (Supercrit®) bone allografts.
Patients treated for acetabular reconstruction with Supercrit® allograft at [redacted] between 2005 and 2010 were included in this retrospective study. Patients were reviewed annually, and adverse event, clinical (Postel Merle d'Aubigné (PMA) score), and radiographic data were collected. Implant migration was measured on standard X-rays.
Fifty-one patients, average age 66 years [range 39-90], were treated with 39 Müller reinforcement rings, 11 Bürch-Schneider rings, and one Link® ring via a posterolateral approach in most cases. Acetabular reconstruction required an average of 1.2 femoral head allografts. Full weight-bearing occurred on postoperative day two or at week six in cases of bipolar revision via a complementary transfemoral approach. Average follow-up was 148 months. The PMA score improved significantly from baseline. The survival rate at 12 years with revision for any reason was 91.5% (95% CI 83-98%). The dislocation rate was 17%, but no dislocations occurred in patients receiving a dual mobility cup cemented in the reinforcement ring. Implants were stable with no cage or screw fractures, except in three patients with reconstruction failure.
Supercrit®-processed allogeneic bone combined with metal rings represents a suitable and satisfactory solution for acetabular reconstruction. Postoperative dislocation risk seems to be reduced by cementing a dual mobility cup in the metal ring.
在翻修全髋关节置换术(THA)中,严重的髋臼骨缺损通常采用同种异体骨移植联合金属笼或环进行治疗。本研究的目的是评估使用超临界CO(Supercrit®)同种异体骨进行髋臼重建后的临床和放射学结果。
本回顾性研究纳入了2005年至2010年期间在[具体地点]接受Supercrit®同种异体骨髋臼重建治疗的患者。每年对患者进行复查,收集不良事件、临床(Postel Merle d'Aubigné(PMA)评分)和放射学数据。通过标准X线测量植入物移位情况。
51例患者,平均年龄66岁[范围39 - 90岁],大多数情况下通过后外侧入路使用39个Müller加强环、11个Bürch - Schneider环和1个Link®环进行治疗。髋臼重建平均需要1.2个股骨头同种异体骨。在通过辅助经股骨入路进行双极翻修的病例中,术后第二天或第六周开始完全负重。平均随访148个月。PMA评分较基线有显著改善。因任何原因进行翻修时,12年的生存率为91.5%(95%CI 83 - 98%)。脱位率为17%,但在加强环中使用双动髋臼杯固定的患者未发生脱位。除3例重建失败的患者外,植入物稳定,未发生笼或螺钉骨折。
Supercrit®处理的同种异体骨联合金属环是髋臼重建的一种合适且令人满意的解决方案。在金属环中使用双动髋臼杯固定似乎可降低术后脱位风险。